Long term effectiveness on prescribing of two multifaceted educational interventions: Results of two large scale randomized cluster trials

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Magrini, Nicola ^a   Formoso, Giulio ^a   Capelli, Oreste ^b   Maestri, Emilio ^a   Nonino, Francesco ^a   Paltrinieri, Barbara ^a   Del Giovane, Cinzia ^c   Voci, Claudio ^a   Magnano, Lucia ^a   Daya, Lisa ^b   Marata, Anna Maria ^a  

^a Regional Agency for Health and Social Care   (Italy)

^b Local Health Authority   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ALFUZOSIN; CALCIUM; DUTASTERIDE; FINASTERIDE; IBANDRONIC ACID; MEPIRODIPINE; PRULIFLOXACIN; RALOXIFENE; RISEDRONIC ACID; STRONTIUM RANELATE; TAMSULOSIN; TERAZOSIN; VITAMIN D;

ARTICLE; CLINICAL EDUCATION; CONTROLLED STUDY; DRUG INFORMATION; DRUG UTILIZATION; EDUCATION PROGRAM; GENERAL PRACTITIONER; HUMAN; ITALY; NATIONAL HEALTH SERVICE; OSTEOPOROSIS; PHARMACIST; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIMARY MEDICAL CARE; PROFESSIONAL KNOWLEDGE; PROSTATE HYPERTROPHY; DRUG USE; EDUCATION; ORGANIZATION; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; PUBLIC RELATIONS; RANDOMIZED CONTROLLED TRIAL; STANDARDS;

CONGRESSES AS TOPIC; DRUG INFORMATION SERVICES; DRUG PRESCRIPTIONS; DRUG UTILIZATION REVIEW; GENERAL PRACTITIONERS; INTERPROFESSIONAL RELATIONS; PHARMACISTS; PRACTICE GUIDELINES AS TOPIC;

EID: 84908128405     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109915     Document Type: Article

References (28)

1. Collier J, Iheanacho I (2002) The pharmaceutical industry as an informant. Lancet 360: 1405-1409.
2. Melander H, Ahlqvist-Rastad J, Meijer G, Beermann B (2003) Evidence b(i)ased medicine - selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. BMJ 326: 1171-1173.
3. Ridker PM, Torres J (2006) Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000-2005. JAMA 295: 2270-2276.
4. Dickersin K (2005) Publication bias: Recognizing the problem, understanding its origins and scope, and preventing harm. In: Rothstein H, Sutton A, Borenstein M (eds). Publication bias in meta-analysis: prevention, assessment, and adjustments. London: Wiley, p 11-33.
5. Chan AW (2008) Bias, spin, and misreporting: time for full access to trial protocols and results. PLoS Medicine 5(11): e230. DOI:10.1371/journal.pmed.0050230.
6. Light DW, Lexchin JR (2012) Pharmaceutical research and development: what do we get for all that money? BMJ 345: e4348.
7. The Congress of the United States - Congressional Budget Office (2006) Research and Development in the Pharmaceutical Industry.
8. Graham Dukes MN (2002) Accountability of the pharmaceutical industry. Lancet 360: 1682-1684.
9. Avorn J, Soumerai SB (1983) Improving drug-therapy decisions through educational outreach - a randomized controlled trial of academically based detailing. New Engl J Med 308: 1457-1463.
10. Soumerai SB, Avorn J (1990) Principles of educational outreach (academic detailing) to improve clinical decision making. JAMA 263: 549-556.
11. Simon SR, Majumdar SR, Prosser LA, Salem-Schatz S, Warner C, et al. (2005) Group versus individual academic detailing to improve the use of antihypertensive medications in primary care: a cluster-randomized controlled trial. Am J Med 118: 521-528.
12. O'Brien MA, Rogers S, Jamtvedt G, Oxman AD, Odgaard-Jensen J, et al. (2007) Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD000409. DOI: 10.1002/14651858.CD000409.pub2.
13. Woloshin S, Schwartz LM (2011) Communicating data about the benefits and harms of treatment: a randomized trial. Ann Intern Med 155: 87-96.
14. Woloshin S, Schwartz LM, Welch HG (2008) Know Your Chances. Understanding Health Statistics. Berkeley (CA): University of California Press 2008.
15. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, et al. (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336: 924-926.
16. Nkansah N, Mostovetsky O, Yu C, Chheng T, Beney J, et al. (2010) Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database of Systematic Reviews Issue 7. Art. No.: CD000336. DOI: 10.1002/14651858.CD000336.pub2.
17. Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, et al. (2004) Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 8: 1-352.
18. Formoso G, Liberati A, Magrini N (2001) Practice Guidelines: Useful and "Participative" Method? Survey of Italian Physicians by Professional Setting. Arch Intern Med 161: 2037-2042.
19. Italian Medicines Agency (AIFA) Research & Development Working Group (2010) Feasibility and challenges of independent research on drugs: the Italian Medicines Agency (AIFA) experience. Eur J Clin Invest 40: 69-86.
20. Garattini S, Chalmers I (2009) Patients and the public deserve big changes in evaluation of drugs. BMJ 338: b1025.
21. Magrini N, Formoso G, Marata AM, Capelli O, Maestri E, et al. (2007) Randomised controlled trials for evaluating the prescribing impact of information meetings led by pharmacists and of new information formats, in General Practice in Italy. BMC Health Services Research 7: 158.
22. Formoso G, Marata AM, Magrini N (2007) Social marketing: should it be used to promote evidence-based information? Soc Sci Med 64: 949-953.
23. Schwartz LM (2009) Lost in Transmission - FDA Drug Information That Never Reaches Clinicians. New Engl J Med 361: 1717-1720.
24. Ivers N, Jamtvedt G, Flottorp S, Young JM, Odgaard-Jensen J, et al. (2012) Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database of Systematic Reviews Issue 6. Art. No.: CD000259. DOI: 10.1002/14651858.CD000259.pub3.
25. Donner A, Klar N (1996) Statistical considerations in the design and analysis of community intervention trials. J Clin Epidemiol 49: 435-439.
26. Norman G (2002) Research in medical education: three decades of progress. BMJ 324: 1560-1562.
27. Godwin M, Ruhland L, Casson I, MacDonald S, Delva D, et al. (2003) Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity. BMC Medical Research Methodology 3: 28.
28. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, et al. (2008) Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 337: a1655 doi:10.1136/bmj.a1655.